Roche Holding

Roche Holding will see a 4.2576% revenue growth shaking the market

bazza

Invested

Community Contributor

Published

30 Jan 25

Updated

04 Feb 25

bazza's Fair Value

CHF 302.06

13.5% undervalued

04 Feb

CHF 261.20

-7.8%

2.0%

Author's Valuation

CHF 302.1

13.5% undervalued

bazza's Fair Value

Narrative

Updates0

bazza'sFair Value

CHF 302.1

13.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

2.94%

Pharma revenue growth rate

0.56%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

3.82%

Calculation

CHF 13.60b

Earnings '30

21.07x

PE Ratio '30

CHF 286.51b

Market Cap '30

CHF 286.51b

Market Cap '30

796.79m

No. shares '30

CHF 359.58

Share Price '30

CHF 359.58 Share Price '30

Discounted to 2025 @ 3.61% p.a.

CHF 301.21

Fair Value '25